鄢力,苟鹏,唐芳,李中会,何卫兰,向蓉,卜冬梅
YAN Li,GOU Peng,TANG Fang,LI Zhonghui,HE Weilan,XIANG Rong,PU Dongmei

• 1:成都市妇女儿童中心医院儿童内分泌遗传代谢科

摘要(Abstract)：

目的:探讨重组人生长激素(rh GH)治疗儿童生长激素缺乏症(GHD)的疗效及对部分相关激素水平的影响。方法:64例GHD患儿作为研究对象给予rh GH 1次/d注射治疗,观察治疗前、治疗6个月及12个月时的身高(Ht)、身高标准差积分(Ht-SDS)、生长速率(GV)、体质指数(BMI)、骨龄/实际年龄比值(BA/CA),治疗3个月、6个月、9个月及12个月时身高增值(ΔHt)、身高标准差积分增值(ΔHt-SDS)及GV等生长指标变化,同时检测治疗前、治疗6个月及12个月时患儿的血清游离三碘甲腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素(TSH)、血清胰岛素样生长因子-1(IGF-1)、血清胰岛素样生长因子结合蛋白-3(IGFBP-3)水平,随访12月并记录患儿的不良反应。结果:与治疗前比较,GHD患儿治疗6个月、12个月时的Ht、Ht-SDS及GV明显升高(P<0.05),但BMI、BA/CA比值与治疗前比较差异无统计学意义(P>0.05),且ΔHt、ΔHt-SDS及GV随着治疗时间的延长均呈下降趋势;治疗6个月、12个月时患儿血清的IGF-1、IGFBP-3及FT3水平均显著高于治疗前,治疗12个月时患儿血清的IGF-1、IGFBP-3水平显著高于治疗6个月时的水平(P<0.05),治疗期间患儿无不良反应。结论:rh GH治疗儿童GHD具有明显的促生长效果,且不会对骨龄成熟、体重产生明显影响,但会对甲状腺激素代谢产生一定影响。
Objective: To investigate the effect of recombinant human growth hormone(rh GH) treatment to children with growth hormone deficiency(GHD) and the influence on related hormone levels.Methods: Sixty-four GHD children were recruited and were given rh GH injection once a day(0. 1 ~0. 15 IU/kg) for 6 months. Their body hight(Ht),hight standard deviation integrat(Ht-SDS),growth velocity(GV),body mass index(BMI),bone age/actual age(BA/CA) were observed before and 6 months and 12 months after the treatment. The increases of Ht,and Ht-SDS,and other GV indexes at the 3rd,6th,9th and 12 th months after the treatment were compared. The thyroid hormone,insulin-like growth factor 1(IGF-1),insulin-like growth factor binding protein 3(IGFBP-3) were observed before and 6 months and 12 months after the treatment. The untoward effects of these childred were followed up and recorded. Results: The Ht,Ht-SDS,and GV levels of children were significantly improved in 6 months and 12 months after treatment than before(P < 0. 05),but BMI and BA/CA after treatment were not significantly different from those before(P > 0. 05). The increasing speeds of Ht,Ht-SDS,and GV decreased along with the prolongation of the treatment. The levels of serum IGF-1,IGFBP-3,and FT3 were significantly increased in 6 months and 12 months after the treatment,and the levels of IGF-1 and IGFBP-3 in 12 months after treatment were significantly higher than those in 6months(P < 0. 05). Conclusions: The rh GH treatment has obvious effect to GHD children in promoting growth,and it has not obvious influence on bone age maturation and weight. But it might have an impact on thyroid hormone metabolism.

关键词(KeyWords)： 甲状腺激素;生长激素缺乏症;重组人生长激素;儿童
thyroid hormone;growth hormone deficiency;recombinant human growth hormone;children

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(8156150433);; 四川省卫生厅科研项目基金(090079)

作者(Author): 鄢力,苟鹏,唐芳,李中会,何卫兰,向蓉,卜冬梅
YAN Li,GOU Peng,TANG Fang,LI Zhonghui,HE Weilan,XIANG Rong,PU Dongmei

参考文献(References)：

• [1]王颖,郑荣秀,刘戈力,等.rh GH替代治疗对生长激素缺乏症患儿线性生长及空腹血糖的影响[J].天津医药,2012(2):108-110.
• [2]戴维靖,韩连书.重组人生长激素治疗青春期前生长激素缺乏症的远期疗效观察[J].实用临床医药杂志,2011(7):136-137.
• [3]肖园,董治亚,陆文丽,等.重组人生长激素治疗单纯性生长激素缺乏症和特发性矮小症患儿血清C型利钠肽氨基末端浓度与生长速率的变化[J].中华内分泌代谢杂志,2011(11):887-891.
• [4]刘兆祥,伍学焱.小剂量生长激素治疗改善成人生长激素缺乏症及成人肥胖人群胰岛素敏感性的可能[J].中华医学杂志,2015(9):716-718.
• [5]罗雨萌,阳洪波,朱惠娟,等.42例儿童期起病的成人生长激素缺乏症的临床分析[J].山东大学学报(医学版),2015(10):62-65.
• [6]Miniero R,Altomare F,Rubino M.et al.Effect of recombinant human growth hormone(rh GH)on hemoglobin concentration in children with idiopathic growth hormone deficiency-related anemia[J].Journal of pediatric hematology/oncology:Official journal of the American Society of Pediatric Hematology/Oncology,2012(6):407-411.
• [7]Youngster I,Rachmiel R,Pinhashamiel O,et al.Treatment with recombinant human growth hormone during childhood is associated with increased intraocular pressure[J].Journal of Pediatrics,2012(6):1116-1119.
• [8]陈霞,肖惋翡,冯静,等.基因重组人生长激素治疗生长激素缺乏伴贫血患儿的研究[J].西南国防医药,2013(11):1210-1211.
• [9]梁晓红.重组人生长激素治疗3类青春期前矮小患儿的疗效分析[J].中国妇幼健康研究,2015(2):258-261.
• [10]Meazza C,Elsedfy HH,Pagani S,et al.Metabolic parameters and adipokine profile in growth hormone deficient(GHD)children before and after 12-month GH treatment[J].Hormone and Metabolic Research,2014(3):219-223.
• [11]Glad CAM,Barbosa EJL,Nystrom HF,et al.SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults[J].European journal of endocrinology,2014(1):101-107.
• [12]徐焰,徐修礼,马越云,等.GHD矮小儿童血清IGF-1水平与血铅的相关性研究及其机制探讨[J].中华检验医学杂志,2015(4):238-242.

文章评论(Comment)：